GBP &
Our Partners

In addition to its own research programs, GBP actively in-licenses technologies and participates into research and development collaborations.

Substipharm

Substipharm is a private, French healthcare group headquartered in Paris, France and operating in over 80 countries, with direct presence in Europe and Southeast Asia.

We focus on pharmaceuticals and biologics, each operating through a dedicated division.

GBP &
Our Partners

In addition to its own research programs, GBP actively in-licenses technologies and participates into research and development collaborations.

Government Pharmaceutical Organization

The Government Pharmaceutical Organization (GPO) is a state enterprise which operates under the Ministry of Public Health. It was founded by Princess Srinagarindra, who as regent, affixed the royal signature to the GPO Act of 1966 (B.E. 2509) on 5th August 1966. GPO was established via a merger of the Pharmaceutical Manufacturing Plant (founded 1939) and the Pharmaceutical Department (founded 1901).

GBP &
Our Partners

In addition to its own research programs, GBP actively in-licenses technologies and participates into research and development collaborations.

Siam Bioscience

We have the resolute commitments to improve patients access to high quality and affordable medicines, to facilitate healthcare security, and to care for the health of Thai people and beyonds. Siam Bioscience group has been established since 2009, consisted of 2 major companies–Siam Bioscience Co.,Ltd. and Apexcela Co.,Ltd.

is a tripartite joint-venture

GBP Joint-Venture Shareholders

Substipharm

Experts in developing pharmaceutical dossiers

Government Pharmaceutical Organization

Operating under the Ministry of Public Health

Siam Bioscience

GBP Joint-Venture Shareholders

Siam Bioscience

GPO

Substipharm

Siam Bioscience

GPO

Substipharm